These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22419506)

  • 1. HMG CoA reductase inhibitors, NSAIDs and risk of glioma.
    Ferris JS; McCoy L; Neugut AI; Wrensch M; Lai R
    Int J Cancer; 2012 Sep; 131(6):E1031-7. PubMed ID: 22419506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins and risk of glioma: a nationwide case-control study in Denmark.
    Gaist D; Andersen L; Hallas J; Sørensen HT; Schrøder HD; Friis S
    Br J Cancer; 2013 Feb; 108(3):715-20. PubMed ID: 23322196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis.
    Amirian ES; Ostrom QT; Armstrong GN; Lai RK; Gu X; Jacobs DI; Jalali A; Claus EB; Barnholtz-Sloan JS; Il'yasova D; Schildkraut JM; Ali-Osman F; Sadetzki S; Jenkins RB; Lachance DH; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Johansen C; Houlston RS; Scheurer ME; Shete S; Amos CI; Melin B; Bondy ML
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):555-562. PubMed ID: 30482874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk.
    Shadman M; Newcomb PA; Hampton JM; Wernli KJ; Trentham-Dietz A
    World J Gastroenterol; 2009 May; 15(19):2336-9. PubMed ID: 19452574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of statins or NSAIDs and survival of patients with high-grade glioma.
    Seliger C; Schaertl J; Gerken M; Luber C; Proescholdt M; Riemenschneider MJ; Leitzmann MF; Hau P; Klinkhammer-Schalke M
    PLoS One; 2018; 13(12):e0207858. PubMed ID: 30507932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme.
    Sivak-Sears NR; Schwartzbaum JA; Miike R; Moghadassi M; Wrensch M
    Am J Epidemiol; 2004 Jun; 159(12):1131-9. PubMed ID: 15191930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins as anti-inflammatory agents.
    Weitz-Schmidt G
    Trends Pharmacol Sci; 2002 Oct; 23(10):482-6. PubMed ID: 12368073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin and NSAID use and prostate cancer risk.
    Coogan PF; Kelly JP; Strom BL; Rosenberg L
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):752-5. PubMed ID: 20582910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study.
    Curiel-Lewandrowski C; Nijsten T; Gomez ML; Hollestein LM; Atkins MB; Stern RS
    J Invest Dermatol; 2011 Jul; 131(7):1460-8. PubMed ID: 21390049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom.
    Burr NE; Talboys RJ; Savva S; Clark A; Phillips M; Metcalfe M; Dennison A; Robinson R; Lewis MP; Rhodes M; Rushbrook S; Hart AR
    Dig Dis Sci; 2014 Jul; 59(7):1567-72. PubMed ID: 24535250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic use and the risk of primary adult brain tumor.
    Egan KM; Nabors LB; Thompson ZJ; Rozmeski CM; Anic GA; Olson JJ; LaRocca RV; Chowdhary SA; Forsyth PA; Thompson RC
    Eur J Epidemiol; 2016 Sep; 31(9):917-25. PubMed ID: 26894804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma.
    Seliger C; Meier CR; Becker C; Jick SS; Bogdahn U; Hau P; Leitzmann MF
    PLoS One; 2016; 11(2):e0149293. PubMed ID: 26871579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
    Beales IL; Vardi I; Dearman L; Broughton T
    Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.
    Perchellet JP; Perchellet EM; Crow KR; Buszek KR; Brown N; Ellappan S; Gao G; Luo D; Minatoya M; Lushington GH
    Int J Mol Med; 2009 Nov; 24(5):633-43. PubMed ID: 19787197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
    Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
    Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study.
    Kho PF; Fawcett J; Fritschi L; Risch H; Webb PM; Whiteman DC; Neale RE
    Cancer Causes Control; 2016 Dec; 27(12):1457-1464. PubMed ID: 27817122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.
    Nguyen DM; Richardson P; El-Serag HB
    Gastroenterology; 2010 Jun; 138(7):2260-6. PubMed ID: 20188100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
    Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
    BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.